Strategic Implications of COVID-19 on Biopharma

These are challenging times for governments, public health administrations and the financial markets. While each biopharma company’s primary concern is the health and safety of its team members, the industry also a responsibility to the world to take an active...

2019 Year End Review Biopharma Report

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our 2019 Annual Report: Global Trends in Biopharma Transactions applies the latest data to analyze current activities in the life sciences deal...

2019 Medtech Year End Review Report

Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and financings. Our Medtech 2019 Annual Report: Global Trends in Medtech Transactions applies the latest data to analyze current activities in the medtech deal...

Whitepaper Download: Inside Out

Based on recent acquisition activity by two of the largest pharmaceutical companies, it seems as if the historical orthodoxy that great biopharma companies are made from the inside out may be losing...